Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for National Healthcare (NHC) over the last 16 years, with Q3 2025 value amounting to -$4.0 million.

  • National Healthcare's Deferred Taxes rose 5791.13% to -$4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.0 million, marking a year-over-year increase of 7774.5%. This contributed to the annual value of -$17.9 million for FY2024, which is 21104.37% down from last year.
  • As of Q3 2025, National Healthcare's Deferred Taxes stood at -$4.0 million, which was up 5791.13% from $2.8 million recorded in Q2 2025.
  • National Healthcare's 5-year Deferred Taxes high stood at $5.3 million for Q3 2021, and its period low was -$9.5 million during Q3 2024.
  • Over the past 5 years, National Healthcare's median Deferred Taxes value was -$1.4 million (recorded in 2025), while the average stood at -$1.4 million.
  • Its Deferred Taxes has fluctuated over the past 5 years, first surged by 57004.44% in 2021, then crashed by 65045.32% in 2024.
  • Over the past 5 years, National Healthcare's Deferred Taxes (Quarter) stood at $866000.0 in 2021, then crashed by 217.55% to -$1.0 million in 2022, then plummeted by 570.63% to -$6.8 million in 2023, then skyrocketed by 65.11% to -$2.4 million in 2024, then crashed by 68.18% to -$4.0 million in 2025.
  • Its Deferred Taxes stands at -$4.0 million for Q3 2025, versus $2.8 million for Q2 2025 and -$1.4 million for Q1 2025.